Location History:
- Dornburg-Frickhofen, DE (2001)
- Michelbach, DE (2001 - 2006)
Company Filing History:
Years Active: 2001-2006
Title: The Innovations of Bernhard Giesendorf
Introduction
Bernhard Giesendorf is a notable inventor based in Michelbach, Germany. He has made significant contributions to the field of virology, particularly in the study of the varicella zoster virus (VZV). With a total of 5 patents to his name, Giesendorf's work has advanced the understanding and diagnosis of viral infections.
Latest Patents
Giesendorf's latest patents include the development of immunoreactive proteins and peptides related to the varicella zoster virus. One of his key inventions is the "Varicella zoster virus (VZV) immunoreactive protein VP26 and its diagnostic use." This invention focuses on immunoreactive peptides homologous to specific amino acid positions of the virus protein VP26. It also encompasses nucleic acids that encode these peptides, which are crucial for diagnosing infections caused by the virus. Another significant patent involves immunoreactive regions of glycoprotein gpII of VZV. This invention highlights peptides that correspond to specific segments of amino acids, which are useful for diagnosing varicella zoster virus infections.
Career Highlights
Giesendorf is currently associated with Dade Behring Marburg GmbH, where he continues to innovate in the field of diagnostics. His work has been instrumental in developing methods that enhance the accuracy of viral infection diagnoses.
Collaborations
Throughout his career, Giesendorf has collaborated with esteemed colleagues such as Markus Eickmann and Dorothee Gicklhorn. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Bernhard Giesendorf's contributions to virology and diagnostics are noteworthy. His innovative patents and collaborations have significantly impacted the field, enhancing the understanding and diagnosis of varicella zoster virus infections.